Literature DB >> 10407377

Alveolar echinococcosis in humans: the current situation in Central Europe and the need for countermeasures.

J Eckert1, P Deplazes.   

Abstract

Alveolar echinococcosis (AE) in humans is caused by a larval stage (metacestode) of Echinococcus multilocularis, which exhibits a tumor-like growth, initially in the liver, with the potential to induce serious disease. At the end of the 1980s, E. multilocularis was known to occur in four countries of Central Europe, but has now been identified in ten countries. Red foxes are the principal definitive hosts of E. multilocularis and sources of human infection, but dogs and cats can also be infected. Growing populations of foxes and their increasing immigration to urban areas are new risk factors. Human AE is rare but its potential high fatality rate, considerable costs of treatment and the persisting infection risk should be reasons for health authorities in European countries to establish coordinated systems of surveillance and risk assessment in combination with measures to reduce morbidity and mortality of AE in the human population. Here, J. Eckert and P. Deplazes outline the current epidemiological situation in Central Europe, and discuss options for surveillance, prevention and control.

Entities:  

Mesh:

Year:  1999        PMID: 10407377     DOI: 10.1016/s0169-4758(99)01476-3

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  38 in total

1.  Analysis of cDNAs coding for immunologically dominant antigens from an oncosphere-specific cDNA library of Echinococcus multilocularis.

Authors:  Armin Merckelbach; Martina Wager; Richard Lucius
Journal:  Parasitol Res       Date:  2003-06-26       Impact factor: 2.289

2.  Echinococcus multilocularis infections in dogs from urban and peri-urban areas in France.

Authors:  Gérald Umhang; Sébastien Comte; Vincent Raton; Vanessa Hormaz; Jean-Marc Boucher; Stéphanie Favier; Benoît Combes; Franck Boué
Journal:  Parasitol Res       Date:  2014-04-01       Impact factor: 2.289

3.  Isolation and characterization of a secretory component of Echinococcus multilocularis metacestodes potentially involved in modulating the host-parasite interface.

Authors:  Mirjam Walker; Adriana Baz; Sylvia Dematteis; Marianne Stettler; Bruno Gottstein; Johann Schaller; Andrew Hemphill
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  [Parasite detection and symptoms of parasitic diseases. 1: Blood parasites].

Authors:  D Eichenlaub; S Eichenlaub
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

5.  Impact of affected lymph nodes on long-term outcome after surgical therapy of alveolar echinococcosis.

Authors:  Andreas Hillenbrand; Annika Beck; Wolfgang Kratzer; Tilmann Graeter; Thomas F E Barth; Julian Schmidberger; Peter Möller; Doris Henne-Bruns; Beate Gruener
Journal:  Langenbecks Arch Surg       Date:  2018-06-16       Impact factor: 3.445

6.  Metastatic and prognostic factors in patients with alveolar echinococcosis.

Authors:  Hui Wang; Chang Lu; Xia Liu; Wei Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  In vitro and in vivo activities of dicationic diguanidino compounds against Echinococcus multilocularis metacestodes.

Authors:  Tatiana Küster; Nadja Kriegel; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

8.  [Detection of parasites and symptoms of parasitic diseases. 2: Parasites of the gastrointestinal tract, tissue and organ parasites, ecto- and skin parasites].

Authors:  D Eichenlaub; S Eichenlaub
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

9.  Spatial distribution of Echinococcus multilocularis, Svalbard, Norway.

Authors:  Eva Fuglei; Audun Stien; Nigel G Yoccoz; Rolf A Ims; Nina E Eide; Pål Prestrud; Peter Deplazes; Antti Oksanen
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

10.  European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000.

Authors:  Petra Kern; Karine Bardonnet; Elisabeth Renner; Herbert Auer; Zbigniew Pawlowski; Rudolf W Ammann; Dominique A Vuitton; Peter Kern
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.